Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
BST-2123 by Bostal Drug Delivery Co for Diabetes: Likelihood of Approval
BST-2123 is under clinical development by Bostal Drug Delivery Co and currently in Phase I for Diabetes. According to GlobalData, Phase I drugs...